William A Petri Selected Research

Cytokines

5/2022	Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
12/2020	IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10.
12/2020	Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection.
12/2019	Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
5/2019	Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection.
1/2017	Role of Eosinophils and Tumor Necrosis Factor Alpha in Interleukin-25-Mediated Protection from Amebic Colitis.
12/2016	Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.
8/2015	Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.
9/2014	The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.
2/2014	Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William A Petri Research Topics

Disease

58	Infections 01/2022 - 01/2002
26	Amebiasis (Amoebiasis) 01/2022 - 01/2002
25	Diarrhea 11/2021 - 11/2008
23	Inflammation (Inflammations) 01/2022 - 10/2002
23	Malnutrition (Nutritional Deficiencies) 01/2022 - 02/2007
14	Growth Disorders 01/2022 - 05/2013
12	Amebic Dysentery (Amoebic Dysentery) 01/2020 - 10/2002
11	Poliomyelitis (Polio) 01/2020 - 01/2014
10	Cryptosporidiosis 01/2022 - 01/2002
9	Liver Abscess 01/2022 - 10/2002
8	Colitis 01/2020 - 11/2008
7	COVID-19 05/2022 - 09/2020
6	Clostridium Infections 03/2020 - 10/2013
5	Cysts 01/2016 - 12/2005
5	Parasitic Diseases (Parasitic Disease) 05/2009 - 01/2002
4	Reinfection 01/2021 - 01/2004
4	Obesity 02/2016 - 01/2014
3	Entamoebiasis 12/2014 - 02/2004
3	Amebic Liver Abscess 08/2010 - 03/2004
2	Sepsis (Septicemia) 01/2022 - 12/2018
2	Genetic Predisposition to Disease (Genetic Predisposition) 05/2021 - 11/2009
2	Lung Diseases (Lung Disease) 03/2021 - 01/2021
2	Cross Infection (Nosocomial Infection) 01/2020 - 01/2014
2	Rotavirus Infections 11/2018 - 10/2018
2	Dysbiosis 01/2018 - 08/2017
2	Fever (Fevers) 01/2016 - 11/2008
2	Tetanus 11/2015 - 05/2015
2	Communicable Diseases (Infectious Diseases) 07/2015 - 12/2014
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014 - 02/2013
1	Respiratory Insufficiency (Respiratory Failure) 05/2022
1	Birth Weight (Birth Weights) 01/2022
1	Premature Birth (Birth, Premature) 01/2022
1	Stillbirth 01/2022
1	Placenta Diseases (Placenta Disorder) 11/2021

Drug/Important Bio-Agent (IBA)

36	VaccinesIBA 01/2022 - 01/2002
16	AntigensIBA 05/2021 - 05/2005
15	Immunoglobulin A (IgA)IBA 01/2021 - 08/2002
13	LectinsIBA 05/2016 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2009
10	CytokinesIBA 05/2022 - 02/2014
10	AntibodiesIBA 01/2021 - 12/2002
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
8	Rotavirus VaccinesIBA 11/2021 - 04/2015
6	C-Reactive ProteinIBA 01/2022 - 01/2016
6	LeptinIBA 02/2016 - 03/2011
6	Thomsen-Friedenreich antigenIBA 01/2011 - 01/2004
5	Immunoglobulin G (IgG)IBA 01/2021 - 08/2002
5	Biological ProductsIBA 09/2020 - 04/2015
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 11/2012
5	EnzymesIBA 01/2018 - 05/2003
5	Leptin ReceptorsIBA 12/2014 - 03/2011
4	Interleukin-4 (Interleukin 4)IBA 05/2022 - 10/2002
4	Interleukin-13IBA 05/2022 - 10/2002
4	ImmunosorbentsIBA 01/2018 - 07/2005
4	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 05/2005
3	dupilumabIBA 05/2022 - 01/2021
3	InterleukinsIBA 05/2022 - 11/2014
3	Blood Group Antigens (Blood Groups)IBA 10/2021 - 11/2018
3	HLA Antigens (Human Leukocyte Antigens)IBA 05/2021 - 02/2004
3	Pharmaceutical PreparationsIBA 01/2021 - 02/2005
3	NeopterinIBA 01/2020 - 11/2015
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020 - 11/2015
3	Interleukin-23 (Interleukin 23)IBA 05/2019 - 09/2013
3	Poliovirus VaccinesIBA 01/2018 - 12/2016
3	LigandsIBA 01/2018 - 01/2008
3	MicronutrientsIBA 06/2017 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 04/2010
3	CarbohydratesIBA 02/2006 - 08/2002
2	Monoclonal AntibodiesIBA 05/2022 - 12/2014
2	Interleukin-33IBA 01/2022 - 01/2019
2	GTP Phosphohydrolases (GTPases)IBA 01/2022 - 01/2021
2	Toll-Like Receptor 2IBA 01/2022 - 11/2016
2	IronIBA 11/2021 - 01/2016
2	RIX4414 vaccineIBA 11/2021 - 01/2018
2	Virulence Factors (Pathogenicity Factors)IBA 10/2021 - 12/2012
2	ProteomeIBA 01/2021 - 01/2012
2	CarbonIBA 01/2021 - 11/2018
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 01/2016
2	guanosine 5'-monophosphorothioateIBA 01/2020 - 10/2016
2	Peroxidase (Myeloperoxidase)IBA 01/2020 - 01/2017
2	ZincIBA 01/2020 - 09/2016
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 05/2019 - 09/2017
2	Lipopolysaccharide ReceptorsIBA 09/2017 - 01/2016
2	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2017 - 12/2016
2	Particulate MatterIBA 04/2014 - 02/2013
2	Metronidazole (Metric)FDA LinkGeneric 01/2013 - 11/2008
2	Glycoproteins (Glycoprotein)IBA 01/2012 - 01/2002
2	Interferon-gamma (Interferon, gamma)IBA 09/2009 - 02/2007
1	Protein Kinase CIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CytidineIBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 03/2021
1	Hyaluronan ReceptorsIBA 03/2021
1	EpitopesIBA 01/2021

Therapy/Procedure

6	Therapeutics 05/2022 - 10/2013
3	Colectomy 01/2022 - 11/2008
1	Critical Care (Surgical Intensive Care) 01/2022
1	Prenatal Care (Care, Prenatal) 01/2022
1	Ileostomy 01/2022